PRESS-RELEASE ·Filed Apr 17, 2026
Press release: dividend
Actionable Insight • Neutral
This is a routine dividend; no strategic shift or financial change is indicated. Traders should monitor for any future adjustments in payout ratio or yield signaling a policy shift.
Final — all horizons settled through T+60d
RPRX ▲ +11.34% at T+60d
NEUTRAL call ✓ call won +11.34% · α vs SPY +5.20% · entry $50.00 → $55.67
T+1d
-1.40%
call -1.40% · α -1.21%
$49.30
settled 6mo ago
T+5d
-1.24%
call -1.24% · α -1.79%
$49.38
settled 5mo ago
T+20d
+6.80%
call +6.80% · α +1.43%
$53.40
settled 5mo ago
T+60d
+11.34%
call +11.34% · α +5.20%
$55.67
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Royalty Pharma announced a quarterly dividend of $0.235 per share, payable June 10, 2026, to shareholders of record as of May 15, 2026. This is a routine capital return with no change in dividend policy or magnitude.
Key Facts
- Royalty Pharma declared a quarterly dividend of $0.235 per Class A ordinary share.
- Dividend payable on June 10, 2026, to shareholders of record on May 15, 2026.
- No change in dividend amount or policy announced.
Financial Impact
Approximately $138 million quarterly (based on ~587 million shares outstanding and $28B market cap)
dividendcash outflow
Risk Factors
- Ongoing insider selling ($1.6M in the last 30 days) may signal muted confidence despite stable dividends.
- Pharma royalty models are sensitive to drug lifecycle risk and patent expirations, though not reflected in this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3276138 |
18 reports for RPRX
100% Hit rate best @ T+60▲ +15.20%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Press Release | $60.59 $58.47 | ▲ +3.50% | ▲ +2.38% | $57.16 (+5.66%) |
Aug 19, 2026 6w ago | Insider Cluster | $61.73 $61.80 | ▲ +0.11% | ▲ +0.50% | $57.16 (−7.40%) |
Aug 12, 2026 7w ago | 144 | $58.56 $60.58 | ▲ +3.45% | ▲ +5.41% | $57.16 (−2.39%) |
Aug 5, 2026 8w ago | 8-K | $57.75 $59.22 | ▲ +2.55% | ▲ +2.19% | $57.16 (−1.02%) |
Jul 2, 2026 13w ago | Insider Cluster | $57.77 $57.96 | ▲ +0.33% | ▼ −0.60% | $57.16 (−1.06%) |
Jul 2, 2026 13w ago | Insider Cluster | $57.77 $57.96 | ▲ +0.33% | ▼ −0.60% | $57.16 (−1.06%) |
May 28, 2026 18w ago | Insider Cluster | $55.76 $55.87 | ▲ +0.20% | ▲ +2.72% | $57.16 (+2.51%) |
May 28, 2026 18w ago | 8-K | $55.76 $54.97 | ▼ −1.42% | ▼ −1.12% | $57.16 (+2.51%) |
May 22, 2026 19w ago | Insider Cluster | $54.50 $55.18 | ▲ +1.25% | ▼ −0.41% | $57.16 (+4.88%) |
May 15, 2026 19w ago | Insider Cluster | $52.07 $53.86 | ▲ +3.44% | ▲ +1.82% | $57.16 (+9.78%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (65h 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access